WASHINGTON, Nov. 5, 2014 /PRNewswire-USNewswire/ -- LUNGevity has issued three Requests for Applications (RFAs) for translational research for the following awards that will be granted in 2015: Career Development Awards, Early Detection Awards, and Targeted Therapeutics Awards. The RFAs are available on the LUNGevity website at www.lungevity.org/rfa and are also posted on the proposalCENTRAL website.
LUNGevity's Career Development Awards for Translational Research program was created to support future research leaders who will keep the field of lung cancer research vibrant with new ideas. Successful applicants may receive $100,000 per year for a possible period of three years and will participate as non-voting members of LUNGevity's Scientific Advisory Board for the duration of the award.
LUNGevity Early Detection Awards support research projects directed at new approaches to improve clinical methods for the early detection and diagnosis of lung cancer. The preference is for studies that are likely to result in patient benefit in the foreseeable future. LUNGevity Targeted Therapeutics Awards support research projects, including immuno-oncology projects, that will make a difference in the clinical treatment and survival of patients.
Applicants for either Early Detection or Targeted Therapeutics Awards may apply as individuals or in multidisciplinary teams of two or more investigators. It is strongly encouraged that teams be composed of principal investigators from different institutions. Individual investigators may receive up to $200,000 over two to three years, while teams of investigators may receive up to $600,000 over two to three years.
LUNGevity supports the largest research awards program of any lung cancer-focused organization in the United States. Since 2002, LUNGevity has funded 110 projects at 57 institutions in 23 states.
About Lung Cancer
- 1 in 14 Americans is diagnosed with lung cancer in their lifetime
- More than 224,000 people in the U.S. will be diagnosed with lung cancer this year
- About 60% of all new lung cancer diagnoses are among people who have never smoked or are former smokers
- Lung cancer kills more people than the next three cancers (colorectal, breast, and pancreatic) combined
- Only 17% of all people diagnosed with lung cancer will survive 5 years or more, BUT if it's caught before it spreads, the chance for 5-year survival improves dramatically
About LUNGevity Foundation
LUNGevity Foundation is firmly committed to making an immediate impact on increasing quality of life and survivorship of people with lung cancer by accelerating research into early detection and more effective treatments, as well as by providing community, support, and education for all those affected by the disease. Our vision is a world where no one dies of lung cancer. For more information about LUNGevity Foundation, please visit www.LUNGevity.org.
SOURCE LUNGevity Foundation